Cell Wall Synthesis Inhibitors: Dr. Mohammed Al-Khawlani
Cell Wall Synthesis Inhibitors: Dr. Mohammed Al-Khawlani
Cell Wall Synthesis Inhibitors: Dr. Mohammed Al-Khawlani
1 Dr. M. Al-Khawlani
Inhibitors of cell wall synthesis
Non B-lactam
b-lactam antibiotics
Other antibiotics
Bacitracin
Vancomycin
Daptomycin
1 -B-Lactam Antibiotics:
AS: Penicillins, Cephalosporin, Carbapenem and Monobactam.
a) Contain B-Lactam ring (essential for anti-
bacterial activity)
d) M.O.A: ↓ Cell Wall Synthesis by bind to specific Penicillin- Binding- Protein (PBP):
3 Dr. M. Al-Khawlani
B-Lactam Antibiotics
▪ Have little or no effect on bacteria that are not growing and dividing
4 Dr. M. Al-Khawlani
B-Lactam Antibiotics
f) Resistance:
- Natural absence of peptidoglycan cell wall e.g. Mycoplasma, Mycobacteria, Fungi, and
Viruses.
- Production of B-lactamase (penicillinases) enzymes. e.g. S. aureus.
- Alteration in the PBP; e.g. MRSA, Pneumococci and enterococci.
- Decreased permeability to antibiotics (eg, Pseudomonas due to loss porin)
5 Dr. M. Al-Khawlani
Penicillin
1. Penicillins:
➢ The disadvantage:
• Acid-sensitive: Not effect orally (given by IV injection).
• Inactivated by B-Lactamase (penicillinase): as Staph. aureus.
• Short acting due to rapid excretion in urine (4-6 h)
• Narrow spectrum
Uses:
- Serious infections: meningitis (especially in babies), gas
gangrene (DOC)
- Diphtheria, anthraxs, Acute & subacute bacterial endocarditis in rheumatic fever and
syphilis
7 Dr. M. Al-Khawlani
Penicillin
▪ Insoluble salts of Penicillin G → allow slow drug absorption with long Duration of action
1) Procaine Penicillin.
- Combination of penicillin G + procaine that have longer duration (12-24 h) and less painful
- Used mainly in: Dose: 1.2 -2.4 million U I.M/ 1-4 Weeks.
- As Prophylaxis in rheumatic fever (β-hemolytic streptococcal infection), 1,200.000 units IM/
month for 5 years or until reaching 21 years age Or penicillin V 250 mg twice daily orally.
- Treatment of syphilis. (single dose)
9 Dr. M. Al-Khawlani
Penicillin
B. Anti-staphylococci penicillin (B-Lactamase Resistant Penicillin)
Ex.
- Methicillin (given I.V only): It is not used now due to its nephrotoxicity
- cloxacillin, dicloxacillin, nafcillin and flucloxacillin (oral or parenteral)
➢ Narrow spectrum, B-Lactamase –resistant, Acid resistant (except methicillin),
Semisynthetic penicillin.
▪ They are active against staphylococci and streptococci (weaker than penicillin G). but
inactive against enterococci, anaerobic bacteria, and gram-negative cocci and rods.
▪ They are given with aminoglycosides (synergistic effect) → treatment of serious infections
(pneumonias, UTI, burns) but should not be mixed in the same syringe or bottle.
❖ Pharmacokinetics:
A) Absorption:
- Most of the penicillin are incompletely absorbed after oral administration, → affect the
composition of the intestinal flora → Superinfection
- Most oral penicillin ( Except amoxicillin) is impaired by food, → should be administered at
least 1–2 hours before or after a meal.
B) Distribution:. low tissue distribution, not pass BBB except in cases of meningitis,
Pass placental (safe in pregnancy).
C) Excretion:
- Renal elimination (Except nafcillin & oxacillin, hepatic metabolism, biliary excreted).
- Probenecid → inhibits renal tubular secretion of penicillin by competing with it →
prolongs penicillin action.
NB: Benzyl penicillin is rapidly excreted and has shortest duration of action.
14 Dr. M. Al-Khawlani
Penicillins
4) Neurotoxicity: Seizures and epileptic fits in case of large doses and patient with renal
failure.
15 Dr. M. Al-Khawlani
Penicillins
❖ Drug interactions
➢ Penicillin (cidal) + Tetracyclines, Chloramphenicol, Erythromycin (static) → Antagonism.
➢ Penicillin + Aminoglycosides → Synergism (but should not be mixed in the same syringe
→ Inactive each other)
❖ Contraindications:
➢ Allergy.
➢ Epilepsy
16 Dr. M. Al-Khawlani